Global Erlotinib Hydrochloride Market Analysis 2011-2017 and Forecast 2018-2023
ReportPage
Report ID
3728
Published Date
28-Aug
No of Report Page
148
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $5,960.00
US $5,960.00
US $2,980.00

  • Report Details 
    Snapshot
    
Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epider
    More...
  • Table Of Content 
    Table of Content
    
1 Industry Overview
    
    1.1 Erlotinib Hydrochloride Industry
    
        1.1.1 Overview
    
        1.1.2 Development of Erlotinib Hydrochloride
    

        1.2 Market Segment
    
        1.2.1 Upstream
    
        1.2.2 Downstream
    
    1.3 Cost Analysis
    

    2 Industry Environment
    
    2.1 Policy
    
    2.2 Economics
    
    2.3 Sociology
    
    2.4 Technology
    

    3 Erlotinib Hydrochloride Market by Type
    
    3.1 Segmen
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Survey No. 3/1,4/1/3 Rajwade Commercial Complex Office No. 8, Phase 2 Behind SBI Bank, Pune - Bengaluru Hwy, Ambegaon BK, Pune, Maharashtra 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -